Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma.
Weber F, Asher A, Bucholz R, Berger M, Prados M, Chang S, Bruce J, Hall W, Rainov NG, Westphal M, Warnick RE, Rand RW, Floeth F, Rommel F, Pan H, Hingorani VN, Puri RK. Weber F, et al. Among authors: hingorani vn. J Neurooncol. 2003 Aug-Sep;64(1-2):125-37. doi: 10.1007/BF02700027. J Neurooncol. 2003. PMID: 12952293 Clinical Trial.
Local convection enhanced delivery of IL4-Pseudomonas exotoxin (NBI-3001) for treatment of patients with recurrent malignant glioma.
Weber FW, Floeth F, Asher A, Bucholz R, Berger M, Prados M, Chang S, Bruce J, Hall W, Rainov NG, Westphal M, Warnick RE, Rand RW, Rommell F, Pan H, Hingorani VN, Puri RK. Weber FW, et al. Among authors: hingorani vn. Acta Neurochir Suppl. 2003;88:93-103. doi: 10.1007/978-3-7091-6090-9_15. Acta Neurochir Suppl. 2003. PMID: 14531567 Clinical Trial.
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia.
Fleischmann R, Kerr B, Yeh LT, Suster M, Shen Z, Polvent E, Hingorani V, Quart B, Manhard K, Miner JN, Baumgartner S; RDEA594-111 Study Group. Fleischmann R, et al. Rheumatology (Oxford). 2014 Dec;53(12):2167-74. doi: 10.1093/rheumatology/ket487. Epub 2014 Feb 8. Rheumatology (Oxford). 2014. PMID: 24509406 Clinical Trial.
Phase 2a randomized controlled trial of short-term activity, safety, and pharmacokinetics of a novel nonnucleoside reverse transcriptase inhibitor, RDEA806, in HIV-1-positive, antiretroviral-naive subjects.
Moyle G, Boffito M, Stoehr A, Rieger A, Shen Z, Manhard K, Sheedy B, Hingorani V, Raney A, Nguyen M, Nguyen T, Ong V, Yeh LT, Quart B. Moyle G, et al. Antimicrob Agents Chemother. 2010 Aug;54(8):3170-8. doi: 10.1128/AAC.00268-10. Epub 2010 May 24. Antimicrob Agents Chemother. 2010. PMID: 20498326 Free PMC article. Clinical Trial.
Transducin: a signaling switch regulated by guanine nucleotides.
Ho YK, Hingorani VN, Navon SE, Fung BK. Ho YK, et al. Among authors: hingorani vn. Curr Top Cell Regul. 1989;30:171-202. doi: 10.1016/b978-0-12-152830-0.50008-6. Curr Top Cell Regul. 1989. PMID: 2559829 Review. No abstract available.
14 results